Znn3bq.jpeg
±±¾©Ê¯ÓÍ»¯¹¤Ñ§Ôº2026ÄêÑо¿ÉúÕÐÉú½ÓÊÕµ÷¼Á¹«¸æ
²é¿´: 639  |  »Ø¸´: 9
±¾Ìû²úÉú 1 ¸ö ·­ÒëEPI £¬µã»÷ÕâÀï½øÐв鿴
µ±Ç°Ö»ÏÔʾÂú×ãÖ¸¶¨Ìõ¼þµÄ»ØÌû£¬µã»÷ÕâÀï²é¿´±¾»°ÌâµÄËùÓлØÌû

shawne2008

ľ³æ (ÖøÃûдÊÖ)


[½»Á÷] ÕªÒª·­Òë

Downstream Antibody Purification using Aqueous Two-Phase Extraction

The extraction of antibodies using a polyethyleneglycol(PEG)-citrate aqueous two-phase system(ATPS) was in vestigated.Studies using purified monoclonal antibody(mAb) identified operating ranges for successful phase formation and factors that significantly affected antibody partitioning. The separation of antibody and host cel lprotein(HCP) from clarified cell culture media was examined using statistical design of experiments(DOE). The partitioning of antibody was nearly complete over the entire range of the operating space examined.A model of the HCP partitioning was generated in which both NaCl and citrate concentrations were identified assignificant factors.To achieve the highest purity,the partitioning of HCP
from cell culture fluid into the product containing phase was minimized using a Steepest Descent algorithm.An optimal ATPS consisting of 14.0%(w/w) PEG,8.4%(w/w)citrate,and7.2%(w/w)NaCl at pH7.2 resulted in a product yield of 89%,anapproximate 7.6- fold reduction in HCP levels relative to the clarified cell culture fluid before extraction and an overall purity of 70%.A system consisting of 15%(w/w)PEG,8%(w/w)citrate,and15% (w/w) NaCl at pH5.5 reduced product-related impurities(aggregates and low molecular product fragments)from 40% to less than0.5%while achieving 95% product recovery.At the experimental conditions that were optimized in the batch mode,a scale-up model for the use of counter-current extraction technology was developed to identify potential improvements in purity and recovery tha tcould be realized in the continuous operational mode

» ²ÂÄãϲ»¶

» ÇÀ½ð±ÒÀ²£¡»ØÌû¾Í¿ÉÒԵõ½:

²é¿´È«²¿É¢½ðÌù

ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
A model of the HCP partitioning was generated in which both NaCl and citrate concentrations were identified assignificant factors.½¨Á¢HCP·ÖÀëµÄÄ£ÐÍʵÑ飬ÆäÖÐNaClºÍÄûÃÊËáÁ½ÕßµÄÈܶÈÈ·ÈÏΪ·Ç³£ÖØÒªµÄÒòËØ
7Â¥2011-03-13 16:11:01
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
²é¿´È«²¿ 10 ¸ö»Ø´ð
shawne2008(½ð±Ò+120, ·­ÒëEPI+1): Ò»ÆðÆÀÁ˰ɣ¬ÕûÌåÉÏ»¹ÊDZȽÏÂúÒâµÄ£¬µ«ÊDz¿·Ö»¹ÊDz»¹»×¼È·£¬¸ÐлӦÖú 2011-03-13 21:51:57
Downstream Antibody Purification using Aqueous Two-Phase Extraction
ÀûÓÃË®ÈÜÒºÁ½ÏàÝÍÈ¡µÄ·½·¨¶ÔÏÂÓο¹ÌåµÄ´¿»¯
2Â¥2011-03-13 15:53:19
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
The extraction of antibodies using a polyethyleneglycol(PEG)-citrate aqueous two-phase system() was in vestigated.

Ñо¿ÁËÓþÛÒÒ¶þ´¼£¨PEG£©-ÄûÃÊËá˫ˮÏàÌåϵ£¨ATPS£©ÌáÈ¡¿¹Ìå
3Â¥2011-03-13 15:55:06
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
Studies using purified monoclonal antibody(mAb) identified operating ranges for successful phase formation and factors that significantly affected antibody partitioning. Ñо¿Ê¹Óô¿»¯µ¥¿Ë¡¿¹Ì壨mAb£©Ê¶±ð²Ù×÷°üÀ¨ÏàµÄ³É¹¦ÐγɺÍÓ°Ï쿹Ìå·ÖÀëµÄÒòËØ
4Â¥2011-03-13 15:59:40
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
×î¾ßÈËÆøÈÈÌûÍÆ¼ö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[¿¼ÑÐ] ²ÄÁÏÓ뻯¹¤×¨Ë¶306·ÖÕÒºÏÊʵ÷¼Á +25 ²×º£ÇáÖÛe 2026-04-06 25/1250 2026-04-08 18:52 by »·»¯²Ä-СÉú
[¿¼ÑÐ] Ò»Ö¾Ô¸0703»¯Ñ§ÕÐ61×îÖÕÅÅÃû62»¯Ñ§Çóµ÷¼Á +12 ÕÐ61ÅÅÃû62 2026-04-07 13/650 2026-04-08 15:00 by heqizheng
[¿¼ÑÐ] µç×ÓÐÅÏ¢346 +4 zuoshaodian 2026-04-08 4/200 2026-04-08 11:54 by zzucheup
[¿¼ÑÐ] 281Çóµ÷¼Á +10 Ò¬×ÓÄ¢¹½ 2026-04-06 10/500 2026-04-08 11:43 by zzucheup
[¿¼ÑÐ] Çóµ÷¼Á Ò»Ö¾Ô¸Î÷ÄϽ»Í¨´óѧ085701»·¾³¹¤³Ì 282·Ö +15 ¶à¶à°®³Ôºº±¤ 2026-04-04 16/800 2026-04-08 11:39 by i_cooler
[¿¼ÑÐ] 0703×Ü·Ö331Çóµ÷¼Á +17 ZY-05 2026-04-04 21/1050 2026-04-08 10:16 by screening
[¿¼ÑÐ] ±¾¿ÆÉúÎïÐÅϢѧ£¬×Ü·Ö362 Çó07 08µ÷¼Á +6 qСٻ1210 2026-04-06 6/300 2026-04-07 19:40 by macy2011
[¿¼ÑÐ] Ò»Ö¾Ô¸±±¾©2£¬²ÄÁÏÓ뻯¹¤308Çóµ÷¼Á +16 ÐܶþÏëÉϰ¶ 2026-04-04 17/850 2026-04-07 14:58 by BruceLiu320
[¿¼ÑÐ] 333Çóµ÷¼Á +6 ºÏ³ËÑîϰϦ 2026-04-06 6/300 2026-04-07 09:44 by Öí»á·É
[¿¼ÑÐ] 081200-11408-367ѧ˶Çóµ÷¼Á +4 1_2_3111 2026-04-06 4/200 2026-04-07 08:13 by jp9609
[¿¼ÑÐ] 22408 331·ÖÇóµ÷¼Á +4 y__1 2026-04-06 4/200 2026-04-06 17:26 by ÍÁľ˶ʿÕÐÉú
[¿¼ÑÐ] 344²ÄÁÏÓ뻯¹¤µ÷¼Á +9 µ÷¼ÁÉϰ¶«^ 2026-04-03 9/450 2026-04-04 23:10 by happyddm
[¿¼ÑÐ] Çóµ÷¼Á +4 êɹ¦? 2026-04-03 4/200 2026-04-04 21:58 by hemengdong
[¿¼ÑÐ] 11408 Ò»Ö¾Ô¸Î÷µç£¬277·ÖÇóµ÷¼Á +4 zhouzhen654 2026-04-03 4/200 2026-04-04 18:10 by Öí»á·É
[ÂÛÎÄͶ¸å] ÇóÎÄÏ× 5+3 ys879651$ 2026-04-02 3/150 2026-04-04 17:22 by bobvan
[¿¼ÑÐ] 334Çóµ÷¼Á +8 ÔøÑöÖ® 2026-04-03 8/400 2026-04-04 11:16 by w_xuqing
[¿¼ÑÐ] Çóµ÷¼Á +3 ÐÄÏëÊÂ³É¿É 2026-04-03 3/150 2026-04-03 11:22 by wangjy2002
[¿¼ÑÐ] 309Çóµ÷¼Á +14 ´ô¹½²»ÊÇ´÷·ò 2026-04-02 14/700 2026-04-03 09:42 by À¶ÔÆË¼Óê
[¿¼ÑÐ] »¯Ñ§070300-×Ü·Ö378-Çóµ÷¼Á +5 ŲÒÎ×ÓµÄÅÝÅÝÌÇ 2026-04-02 5/250 2026-04-02 22:20 by ZXlzxl0425
[¿¼ÑÐ] 366Çóµ÷¼ÁÒ»Ö¾Ô¸¶«±±´óѧ +8 ÔËÆøÀ´µÃÈôÓÐËÆÎ 2026-04-02 8/400 2026-04-02 21:39 by dongzh2009
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û